Leonard S. Schleifer

Shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) were trading higher by more than 4 percent early Thursday morning after the company reported its first-quarter results. Regeneron said that it earned $2.57 per share in the first quarter on revenue of $1.2 billion. Wall Street analysts were...